Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, effective February 1, 2025, Nova Scotia is publicly funding Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan injection), ...
Pain, fatigue, and loss of appetite are common symptoms of advanced prostate cancer and its treatment ... on dietary changes that can optimize your health. Your oncologist can also prescribe ...